Skip to main content
ORMP logo
ORMP
(NASDAQ)
Oramed Pharmaceuticals Inc.
$3.42-- (--)
Loading... - Market loading

Oramed Pharmaceuticals (ORMP) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Oramed Pharmaceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Oramed Pharmaceuticals Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2012
Period EndingDec 2025Dec 2024Dec 2023Sep 2023Dec 2022Aug 2021Aug 2020Aug 2019Aug 2018Aug 2017Aug 2012
Revenue & Gross Profit
Revenue2.000.001.341.342.702.702.712.702.452.460.00
Cost of Revenue1.990.190.000.000.000.000.090.090.090.190.00
Gross Profit0.01-0.191.341.342.702.702.622.612.362.270.00
Operating Expenses
Research & Development6.386.328.978.9727.6420.9910.2413.5211.9810.28-1.68
Selling, General & Administrative8.726.468.718.1415.665.944.233.724.082.76-1.20
Operating Expenses15.1012.7817.1117.1143.3026.9314.4717.2416.0613.040.00
Operating Income-15.09-12.78-15.77-15.77-40.60-24.22-11.76-14.63-13.53-10.770.00
Other Income/Expense
Interest Income89.450.0022.898.033.570.350.691.060.900.79-13.13
Interest Expense0.000.85-2.043.580.000.010.000.000.010.010.00
Other Income/Expense88.65-3.14-1.5420.86-0.630.89-0.44-0.45-0.03-0.010.00
Income
Income Before Tax75.32-15.925.095.09-37.66-22.99-11.51-14.06-12.73-10.083.25
Income Tax Expense11.313.180.000.000.10-2.880.190.30-0.800.400.00
Net Income64.05-19.105.535.53-36.56-22.24-11.51-14.36-12.73-10.480.00
Net Income - Continuous Operations64.02-19.105.095.53-37.76-22.24-11.51-14.36-12.73-10.480.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.000.000.000.00
EBITDA-14.97-14.87-15.577.32-37.61-25.04-11.31-14.17-13.49-10.762.90
EBIT-15.09-12.78-15.770.00-37.66-24.220.000.000.000.002.88
Depreciation & Amortization0.120.190.200.200.060.080.010.010.010.010.00
Earnings Per Share
Basic EPS2.00----1.00-1.00-1.00-1.00-1.00-1.00-1.00
Diluted EPS2.00----1.00-1.00-1.00-1.00-1.00-1.00-
Basic Shares Outstanding41.4040.8340.3240.3239.0028.4720.5317.4514.8813.315.88
Diluted Shares Outstanding42.4240.8340.5740.5739.0028.4720.5317.4514.8813.315.88

Frequently Asked Questions About Oramed Pharmaceuticals Financial Statements

What is an income statement?

An income statement shows a company's revenues, expenses, and net income over a specific period. It reveals profitability by starting with revenue and subtracting costs to arrive at net income — the "bottom line" that shows how much the company earned.

What is ORMP's revenue trend?

Review Oramed Pharmaceuticals's quarterly and annual revenue figures in the income statement table above to identify growth trends, seasonal patterns, and year-over-year changes.

What is gross margin?

Gross margin is revenue minus cost of goods sold, expressed as a percentage. It shows how efficiently a company produces its goods or services. Higher gross margins indicate stronger pricing power and lower production costs.

What is operating income?

Operating income (EBIT) is revenue minus operating expenses, excluding interest and taxes. It measures a company's core business profitability before financing costs and tax effects, making it useful for comparing companies with different capital structures.

What is earnings per share (EPS)?

EPS divides net income by outstanding shares, showing the profit attributable to each share. Diluted EPS includes potential shares from stock options and convertible securities, providing a more conservative measure of per-share earnings.